Vincent Pham Named a 2026 Future Texas Business Legend by the Texas Business Hall of Fame

SAN ANTONIO, Texas — The Huang Lab at the Mays Cancer Center at UT Health San Antonio announces that Vincent Pham, Cancer Biology PhD Candidate and Co-Founder and CEO of Powerhouse Therapeutics, has been named a 2026 Future Texas Business Legend by the Texas Business Hall of Fame. He received the Carlos & Malú Alvarez Award, which honors emerging entrepreneurial leaders in Texas.

The recognition reflects Vincent's work translating Huang Lab science into Powerhouse Therapeutics, a company advancing cell therapies for solid tumors. It also reflects his broader role in the Texas life science ecosystem, including his leadership in Nucleate Texas. The award connects rigorous science to the entrepreneurial drive needed to bring new therapies toward patients.

"This honor belongs to the whole team and to the science that made the company possible," said Vincent. "Building a biotech in Texas means betting on both the research and the people, and this recognition affirms that bet."

"Vincent pairs scientific depth with rare entrepreneurial instinct," said Dr. Gang Huang, principal investigator. "Seeing him recognized among Texas business leaders is a proud moment for the lab."

About the Huang Lab

The Huang Lab at UT Health San Antonio is a basic and translational cancer research group within the MD Anderson Mays Cancer Center at UT Health San Antonio. Our team integrates hematology and solid tumor biology with immunology and metabolism to uncover mechanisms and design interventions. We advance cell and biologic therapies, including CAR T-cell approaches for solid tumors. We also conduct research in trauma and military health. We move discoveries toward clinical impact through product development and collaborations with clinicians and industry. Education and mentorship are core to our mission. We train students, postdoctoral fellows, and early-career scientists in rigorous, multidisciplinary research. Together, we aim to deliver therapies and technologies that improve patient outcomes.